Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

ClinicalTrials.gov ID: NCT06664619

Public ClinicalTrials.gov record NCT06664619. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 9, 2026, 11:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 4-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Fluticasone Propionate/Albuterol Sulfate Combination Compared to Fluticasone Propionate, Albuterol Sulfate or Placebo Delivered by Multidose Dry Powder Inhaler in Participants 12 Years and Older With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety and tolerability of Fp/ABS eMDPI administered four times daily over four weeks * To investigate the pharmacokinetics of Fp/ABS eMDPI, ABS eMDPI and Fp eMDPI after administration of a single dose The planned study duration for each participant is approximately 10 weeks, excluding an optional prescreening visit.

Study identification

NCT ID
NCT06664619
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
724 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 11, 2024
Primary completion
Sep 18, 2026
Completion
Sep 18, 2026
Last update posted
Aug 30, 2026

2024 – 2026

United States locations

U.S. sites
91
U.S. states
27
U.S. cities
76
Facility City State ZIP Site status
Teva Investigational Site 12087 Phoenix Arizona 85015 Recruiting
Teva Investigational Site 12144 Phoenix Arizona 85020 Completed
Teva Investigational Site 12104 Tucson Arizona 85715 Completed
Teva Investigational Site 12146 Tucson Arizona 85741 Recruiting
Teva Investigational Site 12102 Little Rock Arkansas 72205 Recruiting
Teva Investigational Site 12154 Encinitas California 92024-2812 Recruiting
Teva Investigational Site 12103 Huntington Beach California 92647 Recruiting
Teva Investigational Site 12068 La Palma California 90623 Recruiting
Teva Investigational Site 12152 Laguna Niguel California 92677 Recruiting
Teva Investigational Site 12145 Long Beach California 90815 Recruiting
Teva Investigational Site 12088 Los Angeles California 90048 Recruiting
Teva Investigational Site 12094 Los Angeles California 93551 Recruiting
Teva Investigational Site 12161 Northridge California 91324 Recruiting
Teva Investigational Site 12105 Oxnard California 93030-5822 Recruiting
Teva Investigational Site 12101 Sacramento California 95821 Completed
Teva Investigational Site 12064 San Jose California 95117 Recruiting
Teva Investigational Site 12109 Upland California 91786 Completed
Teva Investigational Site 12070 Vista California 92083 Completed
Teva Investigational Site 12091 Walnut Creek California 94598 Completed
Teva Investigational Site 12142 Lakewood Colorado 80228 Recruiting
Teva Investigational Site 12098 Lake City Florida 32055-4880 Completed
Teva Investigational Site 12118 Lake Worth Florida 33460-4400 Completed
Teva Investigational Site 12079 Melbourne Florida 32934 Recruiting
Teva Investigational Site 12071 Miami Florida 33126 Recruiting
Teva Investigational Site 12074 Miami Florida 33135 Recruiting
Teva Investigational Site 12086 Miami Florida 33173 Recruiting
Teva Investigational Site 12061 Miami Florida 33174 Completed
Teva Investigational Site 12097 Miami Florida 33175 Recruiting
Teva Investigational Site 12092 Miami Lakes Florida 33014 Completed
Teva Investigational Site 12076 North Miami Beach Florida 33169 Completed
Teva Investigational Site 12095 Palmetto Bay Florida 33157 Completed
Teva Investigational Site 12075 Pompano Beach Florida 33064 Recruiting
Teva Investigational Site 12078 Tampa Florida 33607 Recruiting
Teva Investigational Site 12175 Conyers Georgia 30012 Recruiting
Teva Investigational Site 12156 Boise Idaho 83706 Recruiting
Teva Investigational Site 12162 Westchester Illinois 60154 Recruiting
Teva Investigational Site 12169 Shreveport Louisiana 71105 Recruiting
Teva Investigational Site 12081 Nottingham Maryland 21236 Completed
Teva Investigational Site 12106 Towson Maryland 21204 Recruiting
Teva Investigational Site 12157 White Marsh Maryland 21162-5503 Recruiting
Teva Investigational Site 12119 Boston Massachusetts 02115 Recruiting
Teva Investigational Site 12182 South Dartmouth Massachusetts 02747 Recruiting
Teva Investigational Site 12187 Brighton Michigan 48116 Recruiting
Teva Investigational Site 12073 Minneapolis Minnesota 55402-2606 Completed
Teva Investigational Site 12066 Richfield Minnesota 55423 Completed
Teva Investigational Site 12149 Columbia Missouri 65203 Recruiting
Teva Investigational Site 12108 St Louis Missouri 63110 Recruiting
Teva Investigational Site 12089 St Louis Missouri 63141 Recruiting
Teva Investigational Site 12158 Hastings Nebraska 68901 Recruiting
Teva Investigational Site 12160 Las Vegas Nevada 89113 Recruiting
Teva Investigational Site 12150 Las Vegas Nevada 89119 Recruiting
Teva Investigational Site 12110 Jersey City New Jersey 07306 Recruiting
Teva Investigational Site 12115 Charlotte North Carolina 28207 Recruiting
Teva Investigational Site 12185 High Point North Carolina 27260 Recruiting
Teva Investigational Site 12085 Raleigh North Carolina 27607-6689 Recruiting
Teva Investigational Site 12063 Toledo Ohio 43617 Completed
Teva Investigational Site 12178 Oklahoma City Oklahoma 73120 Recruiting
Teva Investigational Site 12155 Tulsa Oklahoma 74133 Recruiting
Teva Investigational Site 12170 Tulsa Oklahoma 74136 Recruiting
Teva Investigational Site 12117 Clackamas Oregon 97015 Completed
Teva Investigational Site 12151 Portland Oregon 97202 Completed
Teva Investigational Site 12147 Horsham Pennsylvania 19044 Completed
Teva Investigational Site 12072 Philadelphia Pennsylvania 19107 Recruiting
Teva Investigational Site 12114 Pittsburgh Pennsylvania 15241 Recruiting
Teva Investigational Site 12067 Columbia South Carolina 29204 Completed
Teva Investigational Site 12111 Myrtle Beach South Carolina 29572 Completed
Teva Investigational Site 12112 North Charleston South Carolina 29420 Completed
Teva Investigational Site 12107 Rock Hill South Carolina 29732 Recruiting
Teva Investigational Site 12083 Austin Texas 78744 Recruiting
Teva Investigational Site 12060 Austin Texas 78759 Recruiting
Teva Investigational Site 12077 Corsicana Texas 75110-2471 Completed
Teva Investigational Site 12179 Cypress Texas 77429 Recruiting
Teva Investigational Site 12159 Dallas Texas 75225-6301 Recruiting
Teva Investigational Site 12171 Dallas Texas 75235 Recruiting
Teva Investigational Site 12090 Dallas Texas 75243 Recruiting
Teva Investigational Site 12143 El Paso Texas 79912 Recruiting
Teva Investigational Site 12181 Houston Texas 77008-1528 Recruiting
Teva Investigational Site 12168 Houston Texas 77018 Recruiting
Teva Investigational Site 12184 Houston Texas 77065 Recruiting
Teva Investigational Site 12176 Kerrville Texas 78028 Recruiting
Teva Investigational Site 12080 Kingwood Texas 77339 Completed
Teva Investigational Site 12096 McKinney Texas 75069 Recruiting
Teva Investigational Site 12113 Mesquite Texas 75150 Recruiting
Teva Investigational Site 12166 Sugar Land Texas 77479 Recruiting
Teva Investigational Site 12183 Tomball Texas 77081 Recruiting
Teva Investigational Site 12084 Victoria Texas 77901 Recruiting
Teva Investigational Site 12148 Pleasant View Utah 84404-4791 Recruiting
Teva Investigational Site 12082 Salt Lake City Utah 84123 Completed
Teva Investigational Site 12153 South Ogden Utah 84405 Recruiting
Teva Investigational Site 12093 Portsmouth Virginia 23703 Completed
Teva Investigational Site 12062 Greenfield Wisconsin 53228 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06664619, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2026 · Synced Sep 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06664619 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →